Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
| 692.80 Delayed Data As of May 27 |  +9.36 / +1.37%Today’s Change | 492.13 Today|||52-Week Range 747.42 | +9.70% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Schleifer Leonard S President & Chief Executive Officer |  Sale | 8/18/2021 | 200,000 | $650.03 | $130.0M | +9.00% |
Schleifer Leonard S President & Chief Executive Officer | Sale | 11/19/2021 | 185,646 | $651.96 | $121.0M | +6.15% |
Schleifer Leonard S President & Chief Executive Officer | Sale | 11/19/2021 | 173,491 | $651.96 | $113.1M | +6.15% |
Schleifer Leonard S President & Chief Executive Officer | Sale | 8/06/2021 | 137,145 | $607.51 | $83.3M | +13.41% |
Schleifer Leonard S President & Chief Executive Officer |  Buy | 11/19/2021 | 239,063 | $270.43 | $64.6M | +6.15% |
Schleifer Leonard S President & Chief Executive Officer | Sale | 8/06/2021 | 91,430 | $607.51 | $55.5M | +13.41% |
Schleifer Leonard S President & Chief Executive Officer | Buy | 11/19/2021 | 281,250 | $179.13 | $50.4M | +6.15% |
Vagelos P Roy Director | Sale | 8/25/2021 | 49,282 | $667.39 | $32.9M | +3.53% |
Stahl Neil Executive Vice President-Research & Development | Sale | 12/03/2021 | 50,352 | $632.45 | $31.8M | +9.07% |
Vagelos P Roy Director | Sale | 3/14/2022 | 48,103 | $655.29 | $31.5M | +5.54% |
Page of 63